Chinese expert consensus on integrated case management by a multidisciplinary team in CAR-T cell therapy for lymphoma

Author:

Tu Sanfang1,Li Ping2,Mei Heng3,Liu Yang4,Hu Yongxian5,Liu Peng6,Zou Dehui7,Niu Ting8,Xu Kailin9,Wang Li10,Yang Jianmin11,Zhao Mingfeng12,Huang Xiaojun13,Wang Jianxiang7,Hu Yu3,Zhao Weili10,Wu Depei14,Ma Jun15,Qian Wenbin16,Han Weidong4,Li Yuhua1,Liang Aibin2

Affiliation:

1. Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou,Guangdong 510280, China

2. Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China

3. Institute of Hematology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China

4. Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China

5. Center for Bone Marrow Transplantation, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China

6. Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai 200032,China

7. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Division of Pediatric Blood Disease Center, Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China

8. Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

9. Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, China

10. Department of Hematology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

11. Department of Hematology, Changhai Hospital, The Naval Medical University, Shanghai 210000, China

12. Department of Hematology, Tianjin First Central Hospital, The First Affiliated Central Hospital of Nankai University, The First Central Clinical College of Tianjin Medical University, Tianjin 300192, China

13. Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation Research Unit of Key Technique for Diagnosis and Treatments of Haematologic Malignancies, Chinese Academt of Medical Sciences, Peking University, Beijing 100044, China

14. Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China

15. Harbin Institute of Hematology and Cancer, Harbin, Heilongjiang 150001, China

16. Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3